P
PharmaCyte Biotech Inc (PMCB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$5.67
-1.01 (-15.12%)
Market Cap: $3.77M
Last updated: Nov 16, 2026 at 4:24 PM ET
Earnings
Performance (10Y)
Beat Rate
64%(7/11)Avg Surprise
-37.06%Streak
1 QLast 12 of 39 reported quarters
Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$7.06
SMA 20$6.73
SMA 50$7.38
SMA 200$11.69
EMA 10$6.85
EMA 20$6.91
EMA 50$7.63
EMA 200$11.26
MACD
Line: -0.14Signal: -0.17Hist: 0.03
ADX
ADX: 30.6+DI: 8.7-DI: 1.4
Aroon & PSAR
Aroon Up96.0
Aroon Down88.0
PSAR$0.41
Bollinger Bands
Upper Band$7.95
Lower Band$5.50
%B Position3641%(Upper)
Band Width0.07
RSI (14-Day)
Neutral
35.6
Momentum Oscillators
Stoch %K1370.9
Stoch %D2841.5
Williams %R-31.6
ROC (10d)-3.8%
Momentum-0.23
CCI (20d)278.4
MFI (14d)50.2
Volatility Measures
ATR (14d)$6.04(106.5%)
StdDev (20d)0.61
Hist Vol110.3%(High)
Volume Flow
VWAP$5.93
OBV190.3M
AD Line37.5B
CMF (20d)186.856
Volume Metrics
Avg Vol (20d)191.6K
Vol Ratio0.3x(Low)
VWMA (20d)$7.25
Pivot Points
R3$9.41
R2$8.79
R1$7.74
Pivot Point$7.12
S1$6.06
S2$5.44
S3$4.39
Advanced Oscillators
TSI-7.22
Ultimate Osc96.3
KST-39.35
Financial Data
Related GNG Research
No research available
Be the first to write about PMCB
News
PMCB Valuation and Fair Value
- P/E
- -0.2x
- Forward P/E
- 7.0x
- PEG
- 0.0x
- P/B
- 0.1x
PMCB Profitability: Margins, ROIC and FCF
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -44.0%
PMCB Competitors
Sector: Healthcare
PMCB Bull Case vs Bear Case
Bear case
- PMCB beat EPS estimates in 37.5% of its last 8 reported quarters.
PMCB Earnings: Beat Rate and Next Report
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -56.0%
PMCB Earnings Date
PMCB reports Dec 16, 2026. The date is estimated.
PMCB ETF Holders
GNG tracks 1 ETF that holds PMCB.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Frequently Asked Questions About PMCB
When does PMCB report earnings?
PharmaCyte Biotech Inc (PMCB) is expected to report earnings on Dec 16, 2026.
Does PMCB pay dividends?
PharmaCyte Biotech Inc (PMCB) does not currently pay a regular dividend.
What is PMCB's market cap?
PharmaCyte Biotech Inc (PMCB) has a market capitalization of $3.77M with a current stock price of $5.67.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.